These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23850077)

  • 1. A somatic cell defect is associated with the onset of neurological symptoms in a lysosomal storage disease.
    Rodriguez-Gil JL; Larson DM; Wassif CA; Yanjanin NM; Anderson SM; Kirby MR; Trivedi NS; Porter FD; Pavan WJ
    Mol Genet Metab; 2013; 110(1-2):188-90. PubMed ID: 23850077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells.
    Ebrahimi-Fakhari D; Wahlster L; Bartz F; Werenbeck-Ueding J; Praggastis M; Zhang J; Joggerst-Thomalla B; Theiss S; Grimm D; Ory DS; Runz H
    Hum Mol Genet; 2016 Aug; 25(16):3588-3599. PubMed ID: 27378690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of age of onset and clinical severity in Niemann-Pick disease type C1 with lysosomal abnormalities and gene expression.
    Baxter LL; Watkins-Chow DE; Johnson NL; Farhat NY; Platt FM; Dale RK; Porter FD; Pavan WJ; Rodriguez-Gil JL
    Sci Rep; 2022 Feb; 12(1):2162. PubMed ID: 35140266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
    Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium.
    Lloyd-Evans E; Morgan AJ; He X; Smith DA; Elliot-Smith E; Sillence DJ; Churchill GC; Schuchman EH; Galione A; Platt FM
    Nat Med; 2008 Nov; 14(11):1247-55. PubMed ID: 18953351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease.
    Chen J; Soni RK; Xu Y; Simoes S; Liang FX; DeFreitas L; Hwang R; Montesinos J; Lee JH; Area-Gomez E; Nandakumar R; Vardarajan B; Marquer C
    EBioMedicine; 2023 Jun; 92():104628. PubMed ID: 37245481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1.
    Speak AO; Te Vruchte D; Davis LC; Morgan AJ; Smith DA; Yanjanin NM; Simmons L; Hartung R; Runz H; Mengel E; Beck M; Imrie J; Jacklin E; Wraith JE; Hendriksz C; Lachmann R; Cognet C; Sidhu R; Fujiwara H; Ory DS; Galione A; Porter FD; Vivier E; Platt FM
    Blood; 2014 Jan; 123(1):51-60. PubMed ID: 24235134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.
    Sun X; Marks DL; Park WD; Wheatley CL; Puri V; O'Brien JF; Kraft DL; Lundquist PA; Patterson MC; Pagano RE; Snow K
    Am J Hum Genet; 2001 Jun; 68(6):1361-72. PubMed ID: 11349231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.
    Pipalia NH; Subramanian K; Mao S; Ralph H; Hutt DM; Scott SM; Balch WE; Maxfield FR
    J Lipid Res; 2017 Apr; 58(4):695-708. PubMed ID: 28193631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered vitamin E status in Niemann-Pick type C disease.
    Ulatowski L; Parker R; Davidson C; Yanjanin N; Kelley TJ; Corey D; Atkinson J; Porter F; Arai H; Walkley SU; Manor D
    J Lipid Res; 2011 Jul; 52(7):1400-10. PubMed ID: 21550990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease.
    Tamura A; Yui N
    J Biol Chem; 2015 Apr; 290(15):9442-54. PubMed ID: 25713067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts.
    Yu T; Chung C; Shen D; Xu H; Lieberman AP
    Hum Mol Genet; 2012 Jul; 21(14):3205-14. PubMed ID: 22505584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-content screen for modifiers of Niemann-Pick type C disease in patient cells.
    Pugach EK; Feltes M; Kaufman RJ; Ory DS; Bang AG
    Hum Mol Genet; 2018 Jun; 27(12):2101-2112. PubMed ID: 29659804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Trafficking Phenotypes of Niemann-Pick C1 Gene Mutations Correlate with Various Alterations in Lipid Storage, Membrane Composition and Miglustat Amenability.
    Brogden G; Shammas H; Walters F; Maalouf K; Das AM; Naim HY; Rizk S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.
    Platt FM
    Biochem Soc Trans; 2023 Oct; 51(5):1777-1787. PubMed ID: 37844193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
    Cougnoux A; Cluzeau C; Mitra S; Li R; Williams I; Burkert K; Xu X; Wassif CA; Zheng W; Porter FD
    Cell Death Dis; 2016 Mar; 7(3):e2147. PubMed ID: 26986514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease.
    Paron F; Dardis A; Buratti E
    J Biotechnol; 2020 Jul; 318():20-30. PubMed ID: 32387451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and pharmacological evidence implicates cathepsins in Niemann-Pick C cerebellar degeneration.
    Chung C; Puthanveetil P; Ory DS; Lieberman AP
    Hum Mol Genet; 2016 Apr; 25(7):1434-46. PubMed ID: 26908626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endo-lysosomal dysfunction and neuronal-glial crosstalk in Niemann-Pick type C disease.
    Malara M; Prestel M; Tahirovic S
    Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220388. PubMed ID: 38368932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Specific iPSC-Derived Neural Differentiated and Hepatocyte-like Cells, Carrying the Compound Heterozygous Mutation p.V1023Sfs*15/p.G992R, Present the "Variant" Biochemical Phenotype of Niemann-Pick Type C1 Disease.
    Völkner C; Liedtke M; Untucht R; Hermann A; Frech MJ
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.